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Abstract
Background—Routine HIV testing, called provider-initiated opt-out HIV testing and counseling
(PITC), is recommended in African countries with high HIV prevalence. However, it is unknown
whether PITC increases access to pediatric HIV care. In 2008 the Baylor International Pediatric
AIDS Initiative implemented PITC (BIPAI-PITC) at a Malawian hospital. We sought to evaluate
the influence of BIPAI-PITC, compared to non-routine HIV testing (NRT), on pediatric HIV care
access.
Methods—Retrospective data from 7,077 pediatric inpatients were collected during sequential
four-month periods of NRT and BIPAI-PITC. In-hospital and one-year outcomes for 337 HIV-
infected and HIV-exposed uninfected inpatients not previously enrolled in HIV care were
analyzed to assess the clinical influence of each testing strategy.
Results—During BIPAI-PITC, a greater proportion of all hospitalized children received HIV
testing (81.0% vs 33.3%, p < 0.001), accessed inpatient HIV-trained care (7.5% vs 2.4%, p <
0.001), enrolled into an outpatient HIV clinic after discharge (3.2% vs 1.3%, p < 0.001), and
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initiated antiretroviral therapy (ART) following hospitalization (1.1% vs 0.6%, p = 0.010)
compared to NRT. Additionally, BIPAI-PITC increased the proportion of hospitalized HIV-
infected and HIV-exposed uninfected children receiving DNA PCR testing (73.5% vs 35.2%, p <
0.001), but did not improve outpatient enrollment or ART initiation of identified HIV-infected
patients.
Conclusions—BIPAI-PITC increases access to inpatient and outpatient pediatric HIV care for
hospitalized children, including DNA PCR testing and ART. Broader implementation of BIPAI-
PITC or similar approaches, along with more pediatric HIV-trained clinicians and improved
defaulter-tracking methods, would improve pediatric HIV service utilization globally.
Keywords
Pediatric HIV; Routine HIV Testing; Provider Initiated HIV Testing and Counseling; Early Infant
Diagnosis; Africa South of the Sahara
INTRODUCTION
Although industrialized countries have nearly eliminated new HIV infections in children,
new pediatric HIV infections and high HIV-related mortality continue in sub-Saharan
Africa.1 In Malawi, one of the most severely affected countries, 12.7% of adults are HIV-
infected and approximately 90,000 children are living with HIV.1, 2 Since 2004, more than
270,000 Malawians have started antiretroviral therapy (ART), although access for HIV-
infected children has been disproportionately lower.3–5 Starting in 2007 Malawi adopted
policies to improve ART access for children, including routine HIV testing (provider-
initiated opt-out HIV testing and counseling [PITC]),6 DNA PCR testing for infant HIV
diagnosis, and in late 2008, universal ART for HIV-infected infants under one year of age.7
While there is high pediatric HIV-related disease burden in African hospitals,8–10 most
clinical interventions target outpatient HIV care. In 2007, the Baylor International Pediatric
AIDS Initiative (BIPAI) began caring for hospitalized HIV-infected and HIV-exposed
uninfected children, and in 2008, BIPAI implemented inpatient pediatric PITC (BIPAI-
PITC) at Kamuzu Central Hospital (KCH) in Malawi.11 Program outcomes for this and
similar initiatives established that in-hospital PITC is acceptable, feasible, and has the
potential to increase pediatric HIV care enrollment.11–13
However, the influence of inpatient PITC on access to pediatric HIV services remains
unknown. Our objective was to assess whether BIPAI-PITC, compared to non-routine HIV
testing (NRT), improves access to pediatric HIV care. We also analyzed outcomes of
patients identified by inpatient HIV testing to help assess whether BIPAI-PITC and similar
routine testing approaches merit wider implementation.
MATERIALS AND METHODS
Study Setting
KCH is a busy, urban referral facility with more than 13,000 pediatric admissions annually
and an 8.5% inpatient pediatric HIV-infection prevalence.11 In 2005, one year after the
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introduction of NRT at KCH,14 BIPAI opened an outpatient HIV clinic, the Baylor College
of Medicine-Abbott Fund Clinical Centre of Excellence (COE), that currently treats more
than 5,000 children.15
BIPAI-PITC has been described in detail11 and is compared with NRT in Figure 1. Briefly,
BIPAI-PITC and NRT used the same number of HIV counselors and pediatric HIV-trained
clinicians. BIPAI-PITC added four volunteer patient escorts and utilized a non-anonymous
HIV testing register that included patient names and hospital bed locations to facilitate
linkage between testing and care. Patient escorts were caregivers of HIV-infected children
who displayed competent language skills. They coordinated patient flow and encouraged
caregivers by sharing their own HIV experiences. Each escort received remuneration (2
USD/day) for food and transportation to work. During NRT, healthcare providers offered
HIV testing based on the child’s clinical presentation or physical examination findings,
while during BIPAI-PITC testing was routinely offered irrespective of these factors.11, 14
Study Design
To compare the two HIV testing strategies while minimizing selection bias from seasonal
admission patterns, we analyzed data from all hospitalized children at KCH from September
1 to December 31, 2007 (NRT), and from September 1 to December 31, 2008 (BIPAI-
PITC). The entire pediatric inpatient population was included in the initial analysis because
neither the HIV status of every child nor the total number of children eligible to access HIV
care was known. To assess the influence of the HIV testing models on in-hospital and one-
year patient outcomes, we further studied children who received BIPAI inpatient care but
had not received HIV care before hospitalization (Figure 2).
Children classified as HIV-infected were either DNA PCR-positive (if younger than 18
months of age), antibody-positive (if older than 18 months of age), or produced valid HIV-
infected test results. HIV-exposed infants were either breastfeeding from their HIV-infected
mother within six weeks of a negative DNA PCR test, or born to an HIV-infected mother
but without a test result. Alternatively, their HIV-exposed status was known but they were
ineligible for another DNA PCR due to a pending test. If an HIV-exposed infant tested DNA
PCR-positive during hospitalization, the child’s status was re-classified as HIV-infected.
Additionally, if the inpatient DNA PCR result was negative and they had last breastfed
outside the six-week window period, then the patient was re-identified as HIV-uninfected
and excluded from the outcomes analysis. Only the first hospitalization was analyzed for
patients admitted more than once during the study period, irrespective of the child’s HIV-
status.
Two BIPAI clinicians reviewed inpatients on a daily basis, assigning a World Health
Organization (WHO) clinical stage to each HIV-infected child and WHO Integrated
Management of Childhood Illness (IMCI)-based diagnoses to every child upon hospital
discharge.16 Because this study took place at a resource-limited hospital, laboratory tests
were inconsistently available for most conditions. At the time of hospital discharge, BIPAI
clinicians offered HIV-infected and HIV-exposed patients referral to the COE clinic. Patient
outcomes were re-evaluated one year after hospital discharge, and patients who did not
return to the COE clinic for three months were considered lost to follow-up. One-year
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outcome data was obtained for subjects who attended the COE clinic after hospital
discharge.
Statistical methods
Continuous, normally-distributed variables were described by mean and standard deviation,
and compared by student’s t test. Non-normally distributed continuous variables were
described with median and interquartile range, and compared by Mann-Whitney U test.
Categorical variables were analyzed using Pearson’s chi square test, and when more than
two variable categories were present, a significant global test (alpha = 0.05) was followed by
post-hoc pairwise chi square tests, using Bonferroni’s correction to adjust alpha for multiple
variable levels. A comparison was considered significant only when the p value was smaller
than the corrected alpha. All analyses were performed using SPSS software (version 17.0,
SPSS Inc., Chicago, IL).
Ethical Approval
The Malawi National Health Sciences Research Committee and Baylor College of Medicine
institutional review board approved this study. Nationally certified HIV counselors obtained
verbal consent for HIV testing from caregivers according to national guidelines.17 Consent
was waived for study participation because data was collected retrospectively from patient
medical files.
RESULTS
Children admitted to the pediatric ward during both periods of study were similar with
respect to age and gender. Sepsis, gastroenteritis, and severe anemia were more frequently
diagnosed in all children hospitalized during BIPAI-PITC (p < 0.001), irrespective of HIV
status, while malaria comprised the most common diagnosis in either group (Table 1). There
was a trend towards increased mortality in all patients admitted to KCH during BIPAI-PITC
(p = 0.080).
During BIPAI-PITC, 2693 hospitalized children accepted HIV counseling and were either
HIV tested or produced valid HIV test results, representing 81% of all admissions, an
increase from the 33.3% of hospital admissions that accepted HIV counseling with NRT (p
< 0.001, Table 2). No differences were found with respect to age, gender, WHO clinical
stage, CD4-positive cell count percentage, in-hospital mortality, COE clinic enrollment, or
ART initiation between the two identified HIV-infected cohorts (Table 3). In the BIPAI-
PITC cohort, severe acute malnutrition was only half as prevalent as in the NRT cohort
(24.2% vs 43.1%, p = 0.005), while sepsis (40.3% vs 23.1%, p = 0.015) and malaria (24.2%
vs 12.3%, p = 0.048) were nearly twice as prevalent. Although a smaller proportion of
hospitalized HIV-exposed infants were diagnosed with bacterial meningitis during BIPAI-
PITC (2.0% vs 13.0%, p = 0.045), there were no differences with respect to other baseline
characteristics or clinical outcomes (Table 4).
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HIV-infected African children continue to be denied ART due to inadequate and
inaccessible HIV services. Our results show that with a relatively modest investment of
resources, BIPAI-PITC not only increased HIV testing rates, but also increased access to
inpatient pediatric HIV clinicians, outpatient pediatric HIV care, DNA PCR, and ART.
Furthermore, increasing access to inpatient and outpatient pediatric HIV care for
hospitalized HIV-exposed infants during BIPAI-PITC is particularly important in this era of
new PMTCT strategies such as extended post-natal antiretroviral prophylaxis during
breastfeeding.18–22
BIPAI-PITC, compared to NRT, better utilized skilled healthcare personnel in a setting with
inadequate numbers of healthcare providers. During BIPAI-PITC, the total number of HIV-
infected and HIV-exposed patients identified by inpatient HIV testing increased by 163, and
those receiving inpatient and outpatient pediatric HIV care increased by 161 and 58,
respectively, compared to NRT. These results were achieved with the same staffing levels of
HIV counselors and pediatric HIV-trained clinicians, aided by four unskilled volunteer
patient escorts during BIPAI-PITC.
Given that early ART slows disease progression and reduces mortality among HIV-infected
children,23–27 the higher proportion of hospitalized children accessing ART during BIPAI-
PITC achieved a key program objective. Along with the incorporation of recently-revised
WHO guidelines that expand ART eligibility for children,28 wider implementation of similar
inpatient PITC strategies could narrow the gap between children in need of ART and
PMTCT and those who have access to it.
BIPAI-PITC also identified HIV-infected patients with a different set of clinical
presentations. In particular, HIV-infected children during BIPAI-PITC had a higher
proportion of malaria and a lower proportion of severe acute malnutrition, despite these
diagnoses being equally represented in both periods at KCH. These data suggest that NRT
misses many HIV-infected children hospitalized with malaria. One explanation is that these
patients may lack the physical stigmata typical of HIV infection, including marasmus. A
non-routine HIV testing system that relies solely on clinical judgment to refer patients for
HIV testing is therefore more likely to miss HIV-infected patients with non-specific febrile
syndromes.
However, BIPAI-PITC fell short of its ART potential. More than 85% of all identified HIV-
infected patients were ART-eligible during hospitalization, but none were started on ART in
the hospital, and only half of those enrolling in outpatient care initiated ART within one year
of hospital discharge. Furthermore, although BIPAI-PITC improved DNA PCR access, more
than 70% of ART-eligible HIV-infected infants below 18 months of age who followed-up at
the COE clinic failed to start ART within one year of enrollment despite the broadening of
ART eligibility guidelines during BIPAI-PITC. Routine in-hospital ART initiation for
eligible children is one potential means of addressing these shortcomings, but the feasibility
of this strategy needs further evaluation.
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Additionally, we observed high in-hospital and outpatient mortality in the HIV-infected and
HIV-exposed cohorts regardless of the testing approach, confirming reports from
comparable settings.8–10 This high mortality could reflect the severity of disease observed in
HIV-infected children at the time of testing. Specifically, children in both cohorts presented
with advanced WHO clinical stages, low mean CD4-positive cell count percentages, severe
acute malnutrition, severe forms of pneumonia, and sepsis, all of which are highly predictive
of in-hospital mortality in HIV-infected and HIV-exposed children (Preidis GA, McCollum
ED et al unpublished data). Case management guidelines of HIV-infected children with
these diagnoses, while based upon the best available evidence, are in need of further
examination to refine best practices in resource-limited inpatient and outpatient
settings.29–31
Although BIPAI-PITC increased access to pediatric HIV care for all hospitalized children,
we did not find that a higher proportion of identified HIV-infected and HIV-exposed
patients received in-hospital or outpatient HIV care during BIPAI PITC, compared to NRT.
These observations highlight the challenges associated with resource-limited health systems,
rather than inefficiencies of access to care specific to BIPAI-PITC, for two reasons. Firstly,
BIPAI inpatient clinicians nearly tripled their workload to meet the greater inpatient clinical
demands of BIPAI-PITC but were still unable to review every hospitalized patient. While
training additional KCH clinicians in HIV could further increase the proportion of HIV-
infected patients receiving in-hospital HIV care, high government-mandated training fees
along with poor retention of hospital staff would have inflated program costs beyond what
was available at KCH. Secondly, the high outpatient attrition rate during BIPAI-PITC, while
similar to NRT and other reports,32–34 suggests that the hospital’s current strategy to reduce
the number of patients lost-to-follow-up, which utilizes vehicles to visit defaulted patients,
needs re-evaluation. For instance, mechanisms of tracking defaulted patients could be made
more successful and less costly with greater utilization of community volunteers or mobile
phone technology.35
There are limitations to this study. Evaluating overall access to pediatric HIV care with the
general pediatric inpatient population as a common denominator is limited by the inclusion
of HIV-uninfected children. However, this cohort was the most appropriate to assess HIV
care access, given that each testing period includes comparable proportions of unidentified
HIV-infected patients, based upon stable national HIV prevalence data.36 Undiagnosed
HIV-infected children were also likely to distort the in-hospital outcomes of the HIV-
exposed group, given that 37% of HIV-exposed uninfected children did not have a negative
inpatient DNA PCR test result to confirm their current hospital HIV status (data not shown).
Although a potential confounder, this situation accurately reflects the typical clinical
environment encountered by healthcare providers working in government facilities in
resource-constrained countries.
In summary, we found that transitioning from NRT to BIPAI-PITC led to improvements in
hospitalized children’s access to HIV testing, DNA PCR, inpatient and outpatient pediatric
HIV care, and ART, without increasing the number of HIV counselors or pediatric HIV-
trained clinicians. Where resources allow, even greater improvements in access to pediatric
HIV care may be realized by also increasing the number of HIV-trained clinicians and
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utilizing improved defaulter-tracking methods. Thus, the expansion of BIPAI-PITC or
similar systems of inpatient PITC would improve utilization of global pediatric HIV
services.
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Comparison of NRT and BIPAI-PITC. BIPAI-PITC indicates Baylor International Pediatric
AIDS Initiative System of Provider Initiated opt-out HIV Testing and Counseling; NRT,
Non-Routine HIV Testing and Counseling; HIV, human immunodeficiency virus; PITC,
Provider Initiated opt-out HIV Testing and Counseling; COE, Baylor College of Medicine-
Abbott Fund Children’s Clinical Centre of Excellence; KCH, Kamuzu Central Hospital;
ART, antiretroviral therapy.
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Cohort Schema 1a. NRT Program Cohort 1b. BIPAI-PITC Program Cohort. NRT indicates
Non-Routine HIV Testing and Counseling; BIPAI-PITC, Baylor International Pediatric
AIDS Initiative System of Provider Initiated opt-out HIV Testing and Counseling; HIV,
human immunodeficiency virus; BIPAI, Baylor International Pediatric AIDS Initiative.
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TABLE 1








Age in Months, median (IQR) 20.4 (8.7—44.6) 18.8 (9.1—41.6) 0.168
Females, n (%) 1664 (44.3) 1498 (45.1) 0.565
Final Diagnoses, n (%)
  Severe Acute Malnutrition 141 (3.8) 142 (4.3) 0.275
  Severe/Very Severe Pneumonia 709 (18.9) 635 (19.1) 0.832
  Gastroenteritis 368 (9.8) 680 (20.5) <0.001
  Sepsis 555 (14.8) 688 (20.7) <0.001
  Malaria 1853 (49.4) 1620 (48.7) 0.584
  Bacterial Meningitis 180 (4.8) 187 (5.6) 0.120
  Severe Anemia 228 (6.1) 295 (8.9) <0.001
Hospital Outcome of Death, n (%) 237 (6.3) 245 (7.4) 0.080
NRT indicates Non-Routine HIV Testing; BIPAI-PITC, Baylor International Pediatric AIDS Initiative System of Provider Initiated opt-out HIV
Testing and Counseling; IQR, interquartile range.
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TABLE 2
HIV Status and Pediatric HIV Care Received by All Hospitalized Children
NRT September–
December 2007 (n = 3752)
BIPAI-PITC September–
December 2008 (n = 3325)
P
HIV status determined,* n (%) 1248 (33.3) 2693 (81.0) <0.001
HIV status,† n/N (%) <0.001
  HIV-infected 168/1248 (13.5) 236/2693 (8.8) <0.001
  HIV-exposed uninfected 114/1248 (9.1) 209/2693 (7.8) 0.144
  HIV-uninfected 966/1248 (77.4) 2248/2693 (83.5) <0.001
Received in-hospital HIV care,‡ n (%) 88 (2.4) 249 (7.5) <0.001
  HIV status of all children receiving in-hospital HIV care,§ n/N (%) 0.019
    HIV-infected 65/88 (73.9) 149/249 (59.8)
    HIV-exposed uninfected 23/88 (26.1) 100/249 (40.2)
  DNA PCR tests performed,¶ n/N (%) 31/88 (35.2) 183/249 (73.5) <0.001
Pediatric HIV clinic enrollment,‡‖ n (%) 48 (1.3) 106 (3.2) <0.001
  HIV status of all HIV clinic enrollees, n/N (%) 0.018
    HIV-infected 42/48 (87.5) 74/106 (69.8)
    HIV-exposed uninfected 6/48 (87.5) 32/106 (30.2)
Initiated antiretroviral therapy, n (%) 21 (0.6) 37 (1.1) 0.010
*
1248 (100.0%) NRT and 2757 (82.9%) BIPAI-PITC patients were HIV counseled, with 0 (0.0%) NRT and 64 (2.3%) BIPAI-PITC patients
declining subsequent HIV testing.
†
1167 (93.5%) NRT and 2243 (83.3%) BIPAI-PITC patients were classified based on HIV test results obtained during their hospital admission and
81 (6.5%) NRT and 450 (16.7%) BIPAI-PITC patients were classified based on valid HIV test results obtained prior to their hospital admission.
‡
Patients were not enrolled in outpatient HIV care at the time of hospitalization.
§
Seventy (79.5%) NRT and 108 (43.4%) BIPAI-PITC patients were classified based on HIV test results obtained during their hospital admission
and 18 (20.5%) NRT and 141 (56.6%) BIPAI-PITC patients were classified based on valid HIV test results obtained prior to their hospital
admission.
¶
Twenty-one (67.7%) NRT and 81 (44.3%) BIPAI-PITC patients tested HIV DNA PCR positive, and 10 (32.3%) NRT and 102 (55.7%) BIPAI-
PITC patients tested HIV DNA PCR negative.
‖
Patients received outpatient HIV care at the Baylor College of Medicine-Abbott, Fund Children's Clinical Centre of Excellence.
NRT indicates nonroutine HIV testing; BIPAI-PITC, Baylor International Pediatric AIDS Initiative system of provider-initiated opt-out HIV
testing and counseling; HIV, human immunodeficiency virus; IQR, interquartile range.
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TABLE 3
Baseline Characteristics and Outcomes of HIV-infected Hospitalized Children*
NRT September–December
2007 (n = 65)
BIPAI-PITC September–
December 2008 (n = 149)
P
Age in months, media (IQR) 21.4 (8.0–38.2) 15.7 (7.7–32.7) 0.309
Females, n (%) 26 (40.0) 77 (51.7) 0.116
Hospital WHO Stage, n (%) 0.651
  Stage I 7 (10.8) 22 (14.8)
  Stage II 10 (15.4) 15 (10.1)
  Stage III 33 (50.8) 77 (51.7)
  Stage IV 15 (23.1) 35 (23.5)
Hospital CD4-Positive cell count percentage obtained, n (<5 y/o) 28 46
  Mean (SD) 19.9 (8.9) 22.3 (9.4) 0.260
CPT initiation in hospital,† n/N(%) 60/61 (98.4) 139/141 (98.6) 0.905
ART-eligible in hospital,‡ n (%) 60 (92.3) 128 (85.9) 0.187
Final hospital diagnoses, n (%)
  Severe acute malnutrition 28 (43.1) 36 (24.2) 0.005
  Severe/very severe pneumonia 27 (41.5) 63 (42.3) 0.919
  Gastroenteritis 18 (27.7) 38 (25.5) 0.738
  Sepsis 15 (23.1) 60 (40.3) 0.015
  Malaria 8 (12.3) 36 (24.2) 0.048
  Pulmonary tuberculosis 8 (12.3) 15 (10.1) 0.626
In-hospital outcome of death, n (%) 11 (16.9) 22 (14.8) 0.688
Enrollment of referred hospital patients into COE clinic,§ n/N (%) 42/54 (77.8) 74/110 (67.3) 0.165
COE clinic, enrollees initiated on ART, n/N (%) 21/39 (53.9) 37/67 (55.2) 0.891
Duration from HIV test to ART initiation in months, mean (SD) 4.7 (4.3) 4.0 (4.9) 0.563
One year outcome of COE clinic enrollees (Total), n/N (%) 0.610
  Alive and in care 20/42 (47.6) 27/74 (36.5)
  Dead 8/42 (19.0) 15/74 (20.3)
  Lost to follow-up 7/42 (16.7) 13/74 (17.6)
  Transferred out 7/42 (16.7) 19/74 (25.7)
*
Patients were not enrolled in outpatient HIV care at the time of hospitalization.
†
Sixty-one NRT and 141 BIPAI-PITC patients were eligible for CPT initiation. 3 NRT and 6 BIPAI-PITC patients were already on treatment-dose
cotrimoxazole; 1 NRT and 2 BIPAI-PITC patients were too young to initiate CPT.
‡
ART eligibility for NRT patients was determined by WHO and CD4 criteria only. ART eligibility for BIPAI-PITC patients was determined by
WHO, CD4, and age-based criteria. Note that CD4 was available for only 38 (58.5%) NRT children and 56 (3.7.6%) BIPAI-PITC children.
§
Fifty-four (100.0%) NRT and 110 (86.6%) BIPAI-PITC patients were referred to the COE clinic at hospital discharge.
NRT indicates nonroutine HIV testing; BIPAI-PITC, Baylor for International Pediatric AIDS Initiative system of provider-initiated opt-out HIV
testing and counseling; HIV, human immunodeficiency virus; IQR, interquartile range; WHO, World Health Organization; SD, standard deviation;
CPT, cotrimoxazole prophylactic therapy; ART, antiretroviral therapy; COE, Baylor College of Medicine-Abbott Fund Children's Centre of
Excellence.
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TABLE 4
Baseline Characteristics and Outcomes of HIV-exposed Uninfected Hospitalized Children*
NRT September–December
2007 (n = 23)
BIPAI-PITC September–December
2008 (n = 100)
P
Age in months, median (IQR) 6.4 (3.8–9.8) 7.7 (2.5–12.2) 0.881
Females, n (%) 10 (43.5) 47 (47.0) 0.760
CPT initiation in hospital, n/N (%)† 22/22 (100.0) 81/85 (95.3) 0.579
Final hospital diagnoses, n (%)
  Severe acute malnutrition 5 (21.7) 16 (16.0) 0.542
  Severe/very severe pneumonia 6 (26.1) 25 (25.0) 0.914
  Gastroenteritis 10 (43.5) 38 (38.0) 0.627
  Sepsis 7 (30.4) 42 (42.0) 0.307
  Malaria 3 (13.0) 21 (21.0) 0.561
  Bacterial meningitis 3 (13.0) 2 (2.0) 0.045
In-hospital outcome of death, n (%) 5 (21.7) 12 (12.0) 0.311
Enrollment of referred hospital patients into COE, n/N (%) 6/18 (33.3) 32/69 (46.4) 0.320
Final HIV status of COE clinic enrollees, n/N (%) 1.000
  HIV-exposed uninfected 1/6 (16.7) 6/32 (18.8)
  HIV-uninfected 5/6 (83.3) 26/32 (81..3)
One year outcome of COE clinic enrollees, n/N (%) 0.664
  Lost to follow-up 1/6 (16.7) 3/32 (9.4)
  Transferred out 0/6 (0.0) 3/32 (9.4)
  Dischareed from clinic/HIV-uninfected 5/6 (83.3) 26/32 (81.3)
*
Ten NRT patients and 63 BIPAI-PITC patients had negative DNA PCR test results obtained during hospitalization. Patients were not enrolled in
outpatient HIV care at the time of hospitalization.
†
Twenty-two NRT and 85 BIPAI-PITC patients were eligible for CPT initiation. 1 NRT patient and 12 BIPAI-PITC patients were too young to
initiate CPT; 3 BIPAI-PITC patients were already on proscription-dose cotrimoxazole.
NRT indicates nonroutine HIV testing; BIPAI-PITC, Baylor International Pediatric AIDS Initiative system of provider initiated opt-out HIV testing
and counseling; HIV, human immunodeficiency virus; IQR, interquartile range; CPT, cotrimoxazole prophylactic therapy; COE, Baylor College of
Medicine-Abbott Fund Children's Centre of Excellence; SD, standard deviation.
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